CHICAGO, June 27, 2023 ( – The GI Research Foundation today announced that its CA CURE campaign drove the largest grantmaking year in its 60-year history. The campaign advances the understanding, diagnosis, and treatment of gastrointestinal cancers, and it awarded nearly $18.5 million in the fiscal year that will end on June 30.

“This was an exceptional year for us, thanks to the generosity and passion of a Chicago-area family and others. We are honored at the confidence that they put in us, and we’re thrilled to move such an incredible amount of support into the GI-cancer research community so quickly,” said Jackie Casey, the GI Research Foundation’s executive director.

The GI Research Foundation’s Senior Scientific Advisor and Chief of the Section of Gastroenterology, Hepatology and Nutrition at UChicago Medicine, Dr. David Rubin said:

“We went from the idea phase to a very rapid but scientifically rigorous review process and then millions of grant dollars delivered to the GI cancer research community in less than six months. This combination of agility and quality science was driven by the urgent need of those who are suffering and reflects the commitment and ability of the GI Research Foundation Board and its scientific team of advisors.”

Gastrointestinal cancers are the most common type of cancer, and hundreds of thousands of people in the United States are treated every year. One in three cancer deaths globally are the result of GI cancers.

Nine research projects at eight organizations were funded by the GI Research Foundation in FY23 as part of its CA CURE cancer initiative.

Read More…